article thumbnail

UltraSight Expands Access to Cardiac Monitoring with AI

DAIC

tim.hodson Tue, 02/18/2025 - 16:17 Feb. 11, 2025 UltraSight, a company committed to enhancing the efficiency and productivity of cardiac ultrasound,recentlyannounced support from Bristol Myers Squibb (BMS) for a study that aims to improve access to echocardiographic assessments for patients with obstructive hypertrophic cardiomyopathy (oHCM).

article thumbnail

Cardiology in the Spotlight: Enterprise Imaging That Goes Beyond Radiology

CardiacWire

Sectra Cardiology Imaging addresses the long-standing challenge of fragmented cardiac imaging by unifying ECGs, Echo, Cath, Cardiac NM, Vascular, and CT FFR within a single, intuitive interface.

article thumbnail

Abstract TMP19: Implementation of an Outpatient TIA Clinic

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ATMP19-ATMP19, February 1, 2025. If indicated, the patient will be scheduled for an MRI within 24 hours and/or an echocardiogram within 48 hours of the TIA clinic visit. Radiology and cardiology have availability for urgent MRIs and echocardiograms.

article thumbnail

Abstract WP44: Homocysteine mediates the impact of PFO shunt on vascular cognitive impairment

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWP44-AWP44, February 1, 2025. Residual shunt post PFO closure was assessed using transthoracic echocardiogram (TTE) with saline contrast. Background:Patent foramen ovale (PFO) is an independent risk factor for neurovascular injury such as stroke.

article thumbnail

Abstract TP182: Predictors of Utility of Advanced Cardiac Workup in Revealing Anterior Choroidal Artery Stroke Etiology

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ATP182-ATP182, February 1, 2025. Advanced cardiac workup (ACW), including transesophageal echocardiogram (TEE) and implantable loop recorder (ILR) are widely considered a crucial element in the ESUS work-up. The etiology of AChA infarcts remains poorly understood.

Strokes 40
article thumbnail

Artificial Intelligence–Enhanced Risk Stratification of Cancer Therapeutics–Related Cardiac Dysfunction Using Electrocardiographic Images

Circulation: Cardiovascular Quality & Outcomes

Circulation: Cardiovascular Quality and Outcomes, Volume 18, Issue 1 , Page e011504, January 1, 2025. BACKGROUND:Risk stratification strategies for cancer therapeuticsrelated cardiac dysfunction (CTRCD) rely on serial monitoring by specialized imaging, limiting their scalability. A high-risk versus low-risk AI-ECG screen (0.1 fold and 13.5-fold

Cancer 40
article thumbnail

Study: AI Helps Unlock Earlier Heart Failure Detection

DAIC

tim.hodson Mon, 03/03/2025 - 12:09 March 3, 2025 Eko Health has published a peer-reviewed study in JACC Advances evaluating its FDA-cleared AI model for detecting reduced ejection fraction (EF), a common marker of a weakened heart that can't pump blood effectively (also known as heart failure with reduced ejection fraction, HFrEF).